Search results
Results From The WOW.Com Content Network
On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. ... Price Action: ABT stock is down 0. ...
The healthcare stock is lagging the market this year.
*Stock Advisor returns as of December 23, 2024. Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Abbott Laboratories and Intuitive Surgical.
Abbott Laboratories is an American multinational medical devices and health care company with ... Abbott's year-end 2021 stock price was $140.74. [81] [82] Year Revenue
*Stock Advisor returns as of December 30, 2024. David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Abbott Laboratories, Target, and ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Abbott Laboratories wasn’t one of them. The 10 stocks that ...
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois.It is ranked sixth on the list of largest biomedical companies by revenue.In 2023, the company's seat in Forbes Global 2000 was 74, [2] and rank 89 on the 2024 list. [3]
Illinois-based medical devices and health care company Abbott Laboratories’ shares fell over 3% on Tuesday after the company missed earnings and revenue estimates for the first quarter.